Tenon Medical (NASDAQ:TNON – Get Free Report) and ICU Medical (NASDAQ:ICUI – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, profitability, valuation and dividends.
Earnings & Valuation
This table compares Tenon Medical and ICU Medical”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tenon Medical | $3.94 million | 0.96 | -$12.56 million | ($44.87) | -0.03 |
| ICU Medical | $2.23 billion | 2.01 | $730,000.00 | $2.39 | 75.01 |
ICU Medical has higher revenue and earnings than Tenon Medical. Tenon Medical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Tenon Medical has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500.
Institutional & Insider Ownership
22.7% of Tenon Medical shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 17.7% of Tenon Medical shares are held by insiders. Comparatively, 2.1% of ICU Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Analyst Recommendations
This is a breakdown of recent ratings and price targets for Tenon Medical and ICU Medical, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tenon Medical | 1 | 0 | 1 | 0 | 2.00 |
| ICU Medical | 0 | 3 | 4 | 2 | 2.89 |
ICU Medical has a consensus price target of $195.20, suggesting a potential upside of 8.89%. Given ICU Medical’s stronger consensus rating and higher probable upside, analysts clearly believe ICU Medical is more favorable than Tenon Medical.
Profitability
This table compares Tenon Medical and ICU Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Tenon Medical | -305.10% | -907.60% | -152.12% |
| ICU Medical | 2.76% | 8.40% | 4.51% |
Summary
ICU Medical beats Tenon Medical on 13 of the 15 factors compared between the two stocks.
About Tenon Medical
Tenon Medical, Inc. (NASDAQ:TNON) is a medical device company focused on developing and commercializing technologies for the treatment of sacroiliac (SI) joint dysfunction. The SI joint connects the lower spine to the pelvis and can be a source of chronic lower-back and pelvic pain. The company’s primary product is the Catamaran SIJ Fusion System, a minimally invasive surgical system designed to stabilize and fuse the SI joint through a transfixation approach. The system uses a specialized implant and delivery instruments intended to support placement across the SI joint while addressing the underlying source of instability.
About ICU Medical
ICU Medical is a medical technology company that develops, manufactures and markets products used in infusion therapy, vascular access and critical care. Its offerings include infusion pumps and related sets and accessories, IV solutions, needlefree connectors, and products designed to help protect healthcare workers when handling hazardous drugs. Founded in 1984, the company expanded its product portfolio through acquisitions, including the infusion systems business of Hospira in 2017 and Smiths Medical in 2022.
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
